These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 2052529)
1. The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat. Frijlink HW; Franssen EJ; Eissens AC; Oosting R; Lerk CF; Meijer DK Pharm Res; 1991 Mar; 8(3):380-4. PubMed ID: 2052529 [TBL] [Abstract][Full Text] [Related]
2. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles. Pitha J; Gerloczy A; Olivi A J Pharm Sci; 1994 Jun; 83(6):833-7. PubMed ID: 9120816 [TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. McCormack B; Gregoriadis G Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638 [TBL] [Abstract][Full Text] [Related]
4. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans. Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat. Frijlink HW; Visser J; Hefting NR; Oosting R; Meijer DK; Lerk CF Pharm Res; 1990 Dec; 7(12):1248-52. PubMed ID: 2095562 [TBL] [Abstract][Full Text] [Related]
6. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Frijlink HW; Eissens AC; Hefting NR; Poelstra K; Lerk CF; Meijer DK Pharm Res; 1991 Jan; 8(1):9-16. PubMed ID: 2014215 [TBL] [Abstract][Full Text] [Related]
8. Inclusion mode of flurbiprofen with beta-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, and improvements of some pharmaceutical properties of flurbiprofen by complexation. Imai T; Otagiri M; Saitô H; Uekama K Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):354-9. PubMed ID: 3378297 [No Abstract] [Full Text] [Related]
9. Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation. Otagiri M; Imai T; Uekama K J Pharmacobiodyn; 1982 Dec; 5(12):1027-9. PubMed ID: 7169606 [TBL] [Abstract][Full Text] [Related]
10. Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles. Zhao X; Li W; Luo Q; Zhang X Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):61-7. PubMed ID: 23700219 [TBL] [Abstract][Full Text] [Related]
11. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids. Mura P; Maestrelli F; Cirri M Int J Pharm; 2003 Jul; 260(2):293-302. PubMed ID: 12842348 [TBL] [Abstract][Full Text] [Related]
12. Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats. Gerloczy A; Hoshino T; Pitha J J Pharm Sci; 1994 Feb; 83(2):193-6. PubMed ID: 8169787 [TBL] [Abstract][Full Text] [Related]
14. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins. Faucci MT; Mura P Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468 [TBL] [Abstract][Full Text] [Related]
15. Hydroxypropyl-beta-cyclodextrin can modulate the activity of spinally administered sufentanil. Meert TF; Mesens J; Verheyen P; Noorduin H Eur J Anaesthesiol; 1992 Sep; 9(5):399-409. PubMed ID: 1396627 [TBL] [Abstract][Full Text] [Related]
16. Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl. McCandless R; Yalkowsky SH J Pharm Sci; 1998 Dec; 87(12):1639-42. PubMed ID: 10189280 [TBL] [Abstract][Full Text] [Related]
17. The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins. Okimoto K; Rajewski RA; Uekama K; Jona JA; Stella VJ Pharm Res; 1996 Feb; 13(2):256-64. PubMed ID: 8932446 [TBL] [Abstract][Full Text] [Related]
18. Application of 2-hydroxypropyl-beta-cyclodextrin in the assay of acyl-CoA:cholesterol acyltransferase and neutral and acid cholesterol ester hydrolases. Liza M; Romero JR; Chico Y; Fresnedo O; Ochoa B Lipids; 1996 Mar; 31(3):323-9. PubMed ID: 8900462 [TBL] [Abstract][Full Text] [Related]
19. The utility of 2-hydroxypropyl-beta-cyclodextrin as a vehicle for the intracerebral and intrathecal administration of drugs. Yaksh TL; Jang JD; Nishiuchi Y; Braun KP; Ro SG; Goodman M Life Sci; 1991; 48(7):623-33. PubMed ID: 1703620 [TBL] [Abstract][Full Text] [Related]
20. Determination of hydroxypropyl-beta-cyclodextrin in plasma and urine by size-exclusion chromatography with post-column complexation. Szathmary SC J Chromatogr; 1989 Jan; 487(1):99-105. PubMed ID: 2715279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]